79 related articles for article (PubMed ID: 3815342)
1. Isolation of variants resistant to methylglyoxal bis(guanylhydrazone) from adenovirus-transformed rat cells.
Sircar S; Palkonyay L; Rodrigues M; Allaire S; Horvath J; Thirion JP; Weber J
Cancer Res; 1987 Mar; 47(5):1339-43. PubMed ID: 3815342
[TBL] [Abstract][Full Text] [Related]
2. Genetic characterization of adenovirus transformed cell revertants resistant to methylglyoxal bis(guanylhydrazone): evidence for the involvement of three genetic loci.
Alami N; Chopra A; Thirion JP
J Cell Physiol; 1991 May; 147(2):319-25. PubMed ID: 2040663
[TBL] [Abstract][Full Text] [Related]
3. Normalization of epidermal growth factor receptor and transforming growth factor production in drug resistant variants derived from adenovirus transformed cells.
Sircar S; Weber JM
J Cell Physiol; 1988 Mar; 134(3):467-72. PubMed ID: 3258314
[TBL] [Abstract][Full Text] [Related]
4. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone).
Weber JM; Sircar S; Horvath J; Dion P
Cancer Res; 1989 Nov; 49(21):5779-83. PubMed ID: 2571411
[TBL] [Abstract][Full Text] [Related]
5. Isolation of mutant mammalian cells altered in polyamine transport.
Mandel JL; Flintoff WF
J Cell Physiol; 1978 Dec; 97(3 Pt 1):335-43. PubMed ID: 730773
[TBL] [Abstract][Full Text] [Related]
6. Methylglyoxal-bis(guanylhydrazone)-resistant Chinese hamster ovary cells: genetic evidence that more than a single locus controls uptake.
Heaton MA; Flintoff WF
J Cell Physiol; 1988 Jul; 136(1):133-9. PubMed ID: 3397392
[TBL] [Abstract][Full Text] [Related]
7. Isolation and uptake characteristics of adenovirus transformed cell revertants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).
Rodrigues MT; Palkonyay L; Sircar S; Fleurent J; Dessureault J; Weber JM
Biochem Biophys Res Commun; 1987 Sep; 147(2):675-81. PubMed ID: 3632692
[TBL] [Abstract][Full Text] [Related]
8. Resistance to retransformation by adenovirus but not by heterologous oncogenes in an E1-positive transformation revertant cell line may be mediated by a cellular function.
Sircar S; Rodrigues M; Weber JM
Oncogene; 1988 Dec; 3(6):725-8. PubMed ID: 2577877
[TBL] [Abstract][Full Text] [Related]
9. Wild-type adenovirus type 5 transforming genes function as transdominant suppressors of oncogenesis in mutant adenovirus type 5 transformed rat embryo fibroblast cells.
Su ZZ; Leon JA; Jiang H; Austin VN; Zimmer SG; Fisher PB
Cancer Res; 1993 Apr; 53(8):1929-38. PubMed ID: 8385576
[TBL] [Abstract][Full Text] [Related]
10. Isolation and uptake characteristics of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).
Wiseman A; Kramer DL; Porter CW
Cancer Res; 1983 Dec; 43(12 Pt 1):5937-42. PubMed ID: 6315222
[TBL] [Abstract][Full Text] [Related]
11. Retransformation of a revertant cell line with the adenovirus E1 oncogenes and vanadate.
Dessureault J; Weber JM
J Cell Biochem; 1990 Jul; 43(3):293-6. PubMed ID: 2380267
[TBL] [Abstract][Full Text] [Related]
12. "Hit-and-run" transformation by adenovirus oncogenes.
Nevels M; Täuber B; Spruss T; Wolf H; Dobner T
J Virol; 2001 Apr; 75(7):3089-94. PubMed ID: 11238835
[TBL] [Abstract][Full Text] [Related]
13. An ovine adenovirus vector lacks transforming ability in cells that are transformed by AD5 E1A/B sequences.
Xu ZZ; Nevels M; MacAvoy ES; Lockett LJ; Curiel D; Dobner T; Both GW
Virology; 2000 Apr; 270(1):162-72. PubMed ID: 10772988
[TBL] [Abstract][Full Text] [Related]
14. [Inheritable phenotypic normalization of rodent cells transformed by simian adenovirus SA7 E1 oncogenes by singled-stranded oligonucleotides complementary to a long region of integrated oncogenes].
Grineva NI; Borovkova TV; Sats NV; Kurabekova RM; Rozhitskaia OS; Solov'ev GIa; Pantin VI
Genetika; 1995 Aug; 31(8):1043-51. PubMed ID: 7590212
[TBL] [Abstract][Full Text] [Related]
15. Increased cyclin A and decreased cyclin D levels in adenovirus 5 E1A-transformed rodent cell lines.
Buchou T; Kranenburg O; van Dam H; Roelen D; Zantema A; Hall FL; van der Eb A
Oncogene; 1993 Jul; 8(7):1765-73. PubMed ID: 8510923
[TBL] [Abstract][Full Text] [Related]
16. [Transforming and oncogenic properties of the adenovirus genome].
Zalmanzon ES
Eksp Onkol; 1987; 9(3):3-8. PubMed ID: 3301312
[TBL] [Abstract][Full Text] [Related]
17. The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53.
Nevels M; Spruss T; Wolf H; Dobner T
Oncogene; 1999 Jan; 18(1):9-17. PubMed ID: 9926915
[TBL] [Abstract][Full Text] [Related]
18. Modification of uptake and antiproliferative effect of methylglyoxal bis(guanylhydrazone) by treatment with alpha-difluoromethylornithine in rodent cell lines with different sensitivities to methylglyoxal bis(guanylhydrazone).
Alhonen-Hongisto L; Levin VA; Marton LJ
Cancer Res; 1985 Feb; 45(2):509-14. PubMed ID: 3917847
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and ultrastructural characterization of human cell variants resistant to the antiproliferative effects of methylglyoxal bis(guanylhydrazone).
Kramer DL; Zychlinski L; Wiseman A; Porter CW
Cancer Res; 1983 Dec; 43(12 Pt 1):5943-50. PubMed ID: 6416670
[TBL] [Abstract][Full Text] [Related]
20. Ultrastructural changes in the mitochondria of intestinal epithelium of rodents treated with methylglyoxal-bis(guanylhydrazone).
Pleshkewych A; Maurer TC; Porter CW
Cancer Res; 1983 Feb; 43(2):646-52. PubMed ID: 6848185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
